Mr. Moran formerly served as the first president of Synthes Spine, a division of Synthes (USA), the leading skeletal fixation company in the world. During Mr. Moran's tenure as president of Synthes Spine, he helped grow sales from less than $1 million to more than $60 million annually. While at Synthes in total, he helped grow revenue to $400 million. Since leaving Synthes in 1997, Mr. Moran has privately invested in medical companies and is a member of RobinHood Ventures. Mr. Moran has also served and currently serves on the board of directors for numerous life science companies such as such as Anika Therapeutics, Centinel Spine, Paradigm Spine, Power Medical Interventions, Spine Solutions, Ranier Technologies, and Christini Technologies.
Mr. Moran received an MBA from Harvard Business School and his BA from the University of Notre Dame.